No Data
No Data
GoodRx Holdings Is Maintained at Overweight by Keybanc
RBC Capital Maintains GoodRx(GDRX.US) With Buy Rating, Cuts Target Price to $6
KeyBanc Maintains GoodRx(GDRX.US) With Buy Rating, Cuts Target Price to $6
KeyBanc Cuts Price Target on GoodRx Holdings to $6 From $7, Keeps Overweight Rating
GoodRx Unleashes "GoodRx for Pets," Simplifying Access and Reducing Costs for Pet Medications
55% Of This GoodRx Holdings Insider's Holdings Were Sold
ProperMicheleV : I like the way you're thinking. thanks for the information. I've worked for value based care organizations & I'm not sure if VBC is the answer. I believe the answer to reducing health care costs starts with farm subsidies. most of the patients I work with are people of color who have been economically marginalized for generations. they have to buy shitty cheap food to feed the family. mostly corn based products bc corn is heavily subsidized. diabetes, chronic kidney disease, hypertension, chronic heart failure, the list goes on. polychronic conditions are the new normal & companies like uhc love that. Just remember we are all in this together. I'm happy to make less money trading if it means my fellow humans are well.
Tinkering : Thank you for this research.
Personally, I will be looking into them and others for the same reasons you are.